Connect with us

Technology

PureHealth Achieves AED 1.0 billion Net Profit in 1H 2024; EBITDA Soars to AED 2.2 billion

Published

on

PureHealth booked a 53% y-o-y increase in revenue to AED 12.5 billion in H1 2024 following solid growth across its verticals.The Group’s EBITDA grew 15% y-o-y to AED 2.2 billion and it recorded a margin of 17.2% in H1 2024.

ABU DHABI, UAE, July 31, 2024 /PRNewswire/ — PureHealth Holding PJSC (‘PureHealth’ or ‘the Group’) (ADX Symbol: PUREHEALTH), the largest healthcare platform in the Middle East, today announced its financial results for the period ended 30 June 2024. PureHealth recorded a strong revenue increase of 53% y-o-y to AED 12.5 billion in H1 2024 on the back of solid growth booked across the majority of its verticals, primarily from the Hospitals, Insurance and Procurement segments.

Commenting on the results, the Group’s Chairman, Hamad Al Hammadi, said: “PureHealth remains committed to its vision of transforming healthcare delivery in the UAE and beyond. I am pleased to report that the Group has closed out the first half of 2024 with strong performance, which reflects the continued trust our patients place in the quality and breadth of our services. We are committed to progressing our journey as a leading UAE-based healthcare provider with global aspirationswith unwavering focus and determination.”

Revenue from Hospitals grew 83% y-o-y to AED 9.6 billion in H1 2024, primarily driven by the contributions generated from the Group’s acquisitions of Sheikh Shakhbout Medical City (SSMC) and Circle Health Group during the period. The segment’s revenue was also supported by higher patient volumes (OP up 17% y-o-y, IP up 43% y-o-y, and ED up 43% y-o-y)1 along with an 11% increase in overall bed occupancy to 72%, as well as the addition of the National Rehabilitation Center (NRC) to PureHealth’s portfolio during the period.

The Insurance segment’s revenues grew 15% y-o-y to AED 3.3 billion in H1 2024 due to an overall increase in premiums, specifically from the Enhanced Insurance portfolio, as well as from the rise in the segment’s total number of active members to 3.1 million in H1 2024 compared to 2.9 million in H1 2023. Parallel to this, the Procurement and Supply of Medical Related Services segment also supported the Group’s top-line growth for the period. The segment recorded revenue growth of 36% y-o-y to AED 2.7 billion in H1 2024 as the Group onboarded new customers and executed strategic expansions in diagnostics and medical devices as well as across the pharmaceutical and diabetes divisions.

On the strategic front, the Group acquired a 100% stake in Circle Health Group, the UK’s largest independent hospital operator, as well as SSMC, which stands as the UAE’s premier healthcare complex, known for its cutting-edge stem cell therapy facilities and top-tier clinical expertise. Additionally, the Group has offloaded its investments in Yas Clinic Group and Abu Dhabi Stem Cell Center (ADSCC) with effect from April 1, 2024. These divestments enable PureHealth to focus on advancing the specialised healthcare services previously provided at ADSCC and Yas Clinic, now fully integrated into SSMC, which aligns with PureHealth’s overarching strategy to streamline operations and relocate resources towards synergies across the Group as it looks to enhance its focus on advancing specialized healthcare services.

Shaista Asif, Group Chief Executive Officer at PureHealth, said: “The first half of the year has seen us continue to deliver on our growth strategies as we are actively pursuing expansion across both the local and international stages and have delivered on those fronts through the acquisition of Circle Health Group and SSMC. These assets provide us with additional avenues for growth within our Hospitals segment, allowing us to serve a wider patient base across the UAE and establish a stronger international presence.

Moreover, technology continues to be a critical driver of our success. Our recent advancements in digital health and AI solutions are not merely technological accomplishments; they represent transformative tools that have a tangible impact on patient care. These innovations exemplify our commitment to leveraging technology to streamline operations, enhance patient outcomes, and ultimately empower us to deliver on our promise of a healthier future for all.”

The Group has continued to innovate and establish technological advancements through its dedicated technology company PureCS, which powers PureHealth’s digital and technology segment. These include the most recent launch of an AI-powered blood glucose monitoring app, which empowers users to take charge of their health, as well as the significant progress made in the National Unified Medical Records initiative, aggregating millions of records and facilitating better patient care coordination across the UAE.

In terms of profitability, the Group’s EBITDA grew 15% y-o-y to AED 2.2 billion in H1 2024 and yielded an EBITDA margin of 17.2% during the period. The net profit for the Group for H1 2024 is AED 1.0 billion, reflecting a net profit margin of 8.0%.

Shaista provided conclusionary remarks, stating: “Looking ahead, the strong foundation we have built in the first half of 2024 positions us perfectly to capitalise on exciting opportunities and maximise the value creation opportunities for our shareholders. Our commitment to executing on an attractive acquisition pipeline, combined with the Group’s continuous innovation through its technology segment, will continue to fuel our growth engine. We are confident that these advancements will not only expand our reach and serve a wider patient base but will also further solidify PureHealth’s position as a healthcare leader at the forefront of innovation.”

1 Outpatient (OP), inpatient (IP), and emergency department (ED) patient traffic figures from the comparable period exclude Covid-related patient traffic.

About PureHealth

By advancing the Science of Longevity, PureHealth is introducing the healthcare of the future from the United Arab Emirates to the rest of the world. PureHealth is the largest healthcare platform in the Middle East with an ecosystem that challenges lifespans and reimagines health spans. With 100+ hospitals, 300+ clinics, multiple diagnostic centres, health insurance solutions, pharmacies, health tech, procurement, investments and more, its groundbreaking innovations are at the forefront of healthcare as the company is on a mission to unlock time for humankind.

Pure Health’s network comprises: 

SEHA – One of the largest healthcare networks of hospitals and clinics in the UAEAmbulatory Healthcare Services (AHS) – Delivering comprehensive community-based healthcare servicesDaman (The National Health Insurance Company) – The UAE’s leading health insurerThe Medical Office – Overseeing Sheikh Khalifa Hospitals and healthcare facilities established under the initiatives of H.H. The President of the UAERafed – The UAE’s largest healthcare Group Purchasing OrganisationPureLab – Managing and operating the largest network of laboratories in the regionOne Health – A network that provides end-to-end medical solutions to a base of over 300 healthcare service providersThe Life Corner – Abu Dhabi’s first holistic pharmacy, serving the health and wellness establishmentArdent Health Services – The fourth largest privately held acute care hospital operator in the USCircle Health Group – The largest independent operators of hospitals in the UKPureCS – A leading cloud and technology services provider, specialising in IT management and consulting solutions, cybersecurity, cloud services and AI information systemsSheikh Shakhbout Medical City (SSMC) – The UAE’s largest healthcare complex, delivering integrated complex care

To learn more, please visit www.purehealth.ae

 

Photo: https://mma.prnewswire.com/media/2472515/PureHealth_Results.jpg

 

View original content:https://www.prnewswire.co.uk/news-releases/purehealth-achieves-aed-1-0-billion-net-profit-in-1h-2024-ebitda-soars-to-aed-2-2-billion-302210770.html

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Alogent Receives Federal Reserve Authorization to Directly Exchange X9 Check Image Files for Banks and Credit Unions, Expanding its Role as a Payments Infrastructure Provider

Published

on

By

PEACHTREE CORNERS, Ga., April 21, 2026 /PRNewswire/ — Alogent (@AlogentCorp), a global software leader in the banking and financial services market, announced it has been authorized by the Federal Reserve to send and receive X9 check image exchange files on behalf of its financial institution clients, enabling end-to-end check presentment and returns without the need for intermediary processors.

This direct connectivity allows banks and credit unions to consolidate capture, processing, clearing, settlement, and returns within a single, integrated Alogent platform, delivering faster processing, simpler integrations, fewer vendors, and greater operational control.

“Becoming authorized by the Federal Reserve to directly exchange X9 files for both outbound presentment and inbound returns marks a fundamental shift in Alogent’s role in the payments ecosystem,” said Dede Wakefield, CEO of Alogent. “By removing third‑party intermediaries, we’re repositioning Alogent as a core infrastructure provider, giving banks and credit unions a more direct path to the Fed, and a strong foundation as payments continue to modernize toward consolidation and real‑time settlement.”

Key Benefits for Banks and Credit Unions Include:

Direct exchange of X9 check presentment and return files with the Federal Reserve, without intermediary processorsFaster clearing and settlement times for check image exchangeEnd-to-end visibility across forward presentment and returns workflowsSimplified technology integrations and reduced vendor sprawlGreater operational control and transparency across payment workflowsA future‑ready foundation for real‑time and next‑generation Fed services

“This authorization translates our product strategy into tangible operational benefits for banks and credit unions,” said Ashish Bhatia, VP of Product Management at Alogent. “By consolidating critical payment workflows within a single platform, institutions gain simpler operations, stronger oversight, and sustained control.”

As adoption of faster payments and modern settlement models accelerates, Alogent’s direct Federal Reserve connectivity positions both the company and its clients at the center of the evolving U.S. payments infrastructure, while establishing a foundation for potential direct connectivity to additional Federal Reserve services, including FedNow® real‑time payments, Fedwire®, FedACH®, and FedLine®. This authorization places Alogent among a limited group of technology providers trusted to directly exchange check image files with the Federal Reserve on behalf of financial institutions.

About Alogent

Alogent provides proven, end-to-end check payment processing, and enterprise content, information, and loan management platforms, to financial institutions of all sizes, including credit unions, community banks, and some of the largest national and international institutions. Our unique approach spans the entire transaction ecosystem — capturing and digitizing transaction data, exception tracking, and automating entire transaction and loan management workflows so that information is available across the enterprise. Alogent’s solution suites leverage the latest in machine learning and predictive analytics, including enterprise-wide data intelligence and reporting solutions that enable financial institutions to deliver products and services that boost engagement through personalization and data-backed decisions. Learn more about Alogent at www.alogent.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/alogent-receives-federal-reserve-authorization-to-directly-exchange-x9-check-image-files-for-banks-and-credit-unions-expanding-its-role-as-a-payments-infrastructure-provider-302746616.html

SOURCE Alogent

Continue Reading

Technology

yieldWerx and Enlight Technology Extend Design-to-Test Data Continuity Across Taiwan’s Semiconductor Ecosystem

Published

on

By

HSINCHU, Taiwan, April 21, 2026 /PRNewswire/ — yieldWerx is expanding its presence in Taiwan through a collaboration with Enlight Technology Co., Ltd., bringing advanced test data aggregation and analysis capabilities to one of the world’s most concentrated semiconductor markets.

The collaboration combines Enlight Technology’s established role across Taiwan’s semiconductor design, manufacturing, and research landscape with yieldWerx’s expertise in data aggregation and statistical analysis. Together, the companies aim to address the increasing demand for data-driven yield optimization as device complexity grows across advanced packaging, silicon photonics, and heterogeneous integration.

Enlight Technology is the authorized representative of Siemens EDA in Taiwan and provides a portfolio of electronic design automation (EDA), manufacturing execution systems (MES), and engineering solutions spanning IC, silicon photonics, MEMS, PCB, and system-level applications. The company supports semiconductor and electronics customers, including fabless design houses, foundries, OSATs, and system companies, with engagement across more than 100 semiconductor organizations and 300 system companies in the region.

As part of the partnership, the companies will work together to:

Provide localized technical engagement and support aligned with Taiwan’s semiconductor workflows and language requirements.Support improved yield learning cycles and more efficient production ramp across the region.Extend yield analytics capabilities into an ecosystem spanning design, verification, and manufacturing execution.

“We are excited to partner with Enlight Technology as we expand into Taiwan and the broader Asian market. Their deep domain expertise and strong ecosystem presence significantly enhance our ability to deliver scalable, data-driven yield solutions to customers operating at the forefront of semiconductor innovation.” — Aftkhar Aslam, CEO, yieldWerx

“As advanced packaging and silicon photonics drive exponential test data growth, our partnership with yieldWerx equips Taiwan’s ecosystem with powerful statistical analysis. We empower customers to turn complex data into actionable insights, accelerating yield learning and time-to-market” — Su Cheng Yu, General Manager, Enlight Technology

About yieldWerx
yieldWerx is a leading data and yield analytics platform for semiconductor manufacturing, advanced packaging, and photonics I/O. The platform provides end-to-end visibility across wafer probe, optical and electrical wafer acceptance, module assembly, and system-level test. By analyzing this data, yieldWerx helps organizations understand yield performance, variability, and production trends, enabling optimized quality and faster time-to-market.

About Enlight Technology Co., Ltd.
Enlight Technology Co., Ltd. is a Taiwan-based provider of electronic design automation and engineering solutions and serves as the authorized representative of Siemens EDA in Taiwan. The company delivers solutions spanning IC, silicon photonics, MEMS, PCB, DFM, and manufacturing execution systems, supporting customers from IC-level design to system-level integration. With over three decades of experience, Enlight Technology provides customized solutions and technical services to the electronics industry.

For further information, please visit https://www.yieldWerx.com or https://www.enlight-tec.com/.

Company contacts:

yieldWerx
Tina Shimizu
Chief Marketing Director
412529@email4pr.com
+1 888-929-4022

Enlight Technology Co., Ltd.
Jamie Su
Marketing Director
412529@email4pr.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/yieldwerx-and-enlight-technology-extend-design-to-test-data-continuity-across-taiwans-semiconductor-ecosystem-302748158.html

SOURCE yieldWerx

Continue Reading

Technology

Former UK SAS Sargeant Joins Delta Three Oscar to Drive Awareness of Next-Generation Military Protection

Published

on

By

BLACKSBURG, Va., April 21, 2026 /PRNewswire/ — Delta Three Oscar, the military and ballistic protection division of D3O, today announces former UK Special Forces veteran and expedition leader Jay Morton as its first-ever brand ambassador.

 

Morton will bring his military expertise to Delta Three Oscar and will be endorsing the company’s latest impact protection and shock absorbing footwear whilst providing experience backed insights to the team as part of the company’s ongoing innovation into protective equipment.

The partnership is a strategic move for the protection brand to increase awareness and the benefits of its impact and shock absorbing personal protection systems amongst end users. Delta Three Oscar engineers the most advanced ballistic helmet liners, impact protection body armour, and shock absorbing midsoles used in helmets, uniforms, chest plates and footwear worn by U.S. military, NATO forces and law enforcement departments worldwide. The body armour is lightweight, flexible and designed to reduce fatigue by ensuring a comfortable fit with unrivalled impact protection, tough enough to be used in the harshest environments.

Morton served 14 years in the British Armed Forces, including four years in the Parachute Regiment and ten years with the Special Air Service, touring the Afghanistan and Iraq on multiple occasions. His frontline experience and expertise in high-risk environments give him huge credibility to endorse Delta Three Oscar’s next-generation protection designed for elite performance, enhanced comfort, and impact reduction.

Now as an elite expedition leader, Morton has highlighted the importance of trust, comfort, and reliability in protective gear.

“Trust in your protective equipment is absolutely essential,” he said. “When you’re operating in high-risk environments, comfort and reliability are paramount and you can’t afford distractions. Delta Three Oscar’s body and limb protectors deliver exceptional impact and ballistic performance while remaining incredibly comfortable. It’s ‘fit and forget’ protection that allows operators to focus entirely on the mission.”

Delta Three Oscar engineers advanced protection technologies including:

Ballistic body armour protection materials to mitigate back face deformationHALO® helmet suspension systems available in 3, 7 and 9 pad configurationsImpact protection flexible moulded armour for knees and elbows including tough outer shellsUnderfoot shock-absorbing protection used in midsoles

These products and materials are engineered to reduce fatigue, improve comfort, and enhance operational effectiveness in demanding environments.

“Jay brings a huge amount of credibility and real operational insight into what frontline personnel require from their protective equipment,” said Mostyn Thomas, Chief Marketing Officer at Delta Three Oscar. “His experience at the highest level of military performance makes him an ideal partner as we continue advancing protection technology and supporting those who serve, giving them a subconscious advantage by knowing they have the best protection available”

As Delta Three Oscar’s first ambassador, Morton will feature in the company’s latest brand campaign highlighting the benefits of Delta Three Oscar’s unique military protection innovation and performance.

Media Contact:
Serena Thynne
09178533121
412519@email4pr.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/former-uk-sas-sargeant-joins-delta-three-oscar-to-drive-awareness-of-next-generation-military-protection-302748124.html

SOURCE D3O

Continue Reading

Trending